Angelini Pharma and Trueblue enter new collaboration to boost digital transformation and growth with AiDEA’s Artificial Intelligence.
Trueblue, a leading provider of AI solutions for Operational and Analytical CRM for the for Pharma & Life Science markets has announced that Angelini Pharma, as part of a major global digital transformation process, has selected AiDEA, the first AI-Digital Cloud Pharma CRM solution based on Microsoft technologies.
Headquartered in Rome, Italy, Angelini Pharma is a leading pharma company committed to helping patients in the therapeutic areas of Central Nervous System (CNS) and Mental Health (including Pain), Rare Diseases and Consumer Healthcare.
Angelini Pharma to implement the AiDEA CRM suite in more than 24 subsidiaries globally
Angelini Pharma plans to implement the AiDEA CRM suite in more than 24 subsidiaries around the world, providing a broad range of Artificial Intelligence applications to its employees. The leading Pharma Company will thus take advantage of actionable insights and omni-channel optimization algorithms designed to maximize the use of resources, optimize Customer Engagement Activities on all channels and better meet the needs of each stakeholder.
Following a thorough evaluation process of the ideal partner and as a result of a former successful Data Warehouse and Corporate Business Intelligence project, Angelini Pharma chose Trueblue’s, which demonstrated the skills, innovation, flexibility and business advantage of its platforms powered by Microsoft Dynamics 365.
Pierluigi Antonelli, Angelini Pharma’s CEO stated:
“We decided to boost the deployment of our Multichannel strategy to better support our ongoing transformation, and while advancing significantly, we realized the need to further accelerate also expanding to solutions based on the use of Artificial Intelligence. Trueblue’s AiDEA Suite enables us to leverage our existing investments while accelerating our AI transformation to ensure our subsidiaries can better serve their customers”.
On an international level, companies that are strategically scaling AI report almost three times higher returns on investment (ROI) compared to those that are merely experimenting.
Marco Bonesini, CEO & Co-founder of Trueblue said:
“We are excited about this relationship that has been lasting for several years and that makes Angelini Pharma the main player of a new paradigm, in this particularly important historical moment for the pharmaceutical context. Our goal is to contribute to the growth of Angelini Pharma at international level with the strength of AiDEA and all the potential of an omni-channel AI-Driven solution based on Microsoft Dynamics 365, which is truly ready to change the CRM market in the pharmaceutical sector”.
Elena Bonfiglioli, EMEA Healthcare Lead at Microsoft Corp. added:
“AiDEA, enables pharma companies with the capabilities and tools to deliver superior experiences in every interaction with their customers. Integration with Dynamics 365 supports pharma companies in their digital transition.”
For more information please visit: www.truebluecorp.com